Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Medicine To Enter U.S. Market With Weight Loss Tablets

This article was originally published in PharmAsia News

Executive Summary

BEIJING - China Medicine Corp. is preparing to launch its first product in the U.S., a dietary supplement aimed at weight loss and countering obesity, according to the company's CEO

You may also be interested in...



China Medicine Aims To Launch Antitoxin Product For Animal Feed In Australia, China

BEIJING - The head of China Medicine Corp., which distributes over-the-counter drugs and traditional Chinese medicines in China, said the company aims to expand its development of products and to sell beyond China's borders to boost profits during the next several quarters

China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector

BEIJING - China's strengthening regulation of the pharmaceutical sector and expanding national health insurance coverage, along with rising incomes, are all triggering a boom for the country's leading drug makers, according to a new study of the sector

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

LL1123310

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel